Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

07 Mar 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 7, 2022 titled ‘Zydus to launch Oxemia (Desidustat) a breakthrough treatment for Anemia in patients suffering from Chronic Kidney Disease (CKD)’.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1917.35
Dr. Reddys Labs. 1384.50
Cipla 1415.40
Lupin 2020.00
Zydus Lifesciences 1228.10
View more..